Infinity Pharmaceuticals, Inc.

NASDAQ: INFI
$0.49
-$0.06 (-10.9%)
Closing price December 6, 2022
Whole Foods, Synchrony Financial and others led the charge in last week's market pullback and absolutely crushed shareholders.
24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in the session.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Abercrombie & Fitch, Apple, Best Buy, Cisco Systems, Procter & Gamble, Synchrony Financial and U.S....
Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still way down on the day for other reasons.
All the major money management firms that run exchange traded funds have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels.
These are the top analyst upgrades and downgrades covered by 24/7 Wall St. on Thursday, September 4, 2014.
Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.
Source: ThinkstockWhat is one trend you see whenever the stock market hits a new high or enjoys a long period of strength? Usually, companies and their insiders line up in droves to sell stock to...
The stock market is up Tuesday, with the Dow Jones Industrial Average up 0.84%, the Nasdaq up 1.38% and the S&P 500 up 0.90%. Today’s winners include a pharmaceutical company receiving...
Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...
All three major US indexes opened lower this morning following the report that US GDP grew by 2.8% in the fourth quarter. A rise of 3% was expected. Combined with the lack of a solution the Greek...
There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Riverbed...